5231-87-8Relevant articles and documents
An Unsymmetrical Squaraine-Based Activatable Probe for Imaging Lymphatic Metastasis by Responding to Tumor Hypoxia with MSOT and Aggregation-Enhanced Fluorescent Imaging
Lin, Yi,Sun, Lihe,Zeng, Fang,Wu, Shuizhu
, p. 16740 - 16747 (2019)
Optoacoustic imaging has great potential for preclinical research and clinical practice, and designing robust activatable optoacoustic probes for specific diseases is beneficial for its further development. Herein, an activatable probe has been developed for tumor hypoxia imaging. For this probe, indole and quinoline were linked on each side of an oxocyclobutenolate core to form an unsymmetrical squaraine. A triarylamine group was incorporated to endow the molecule with the aggregation enhanced emission (AEE) properties. In aqueous media, the squaraine chromophore aggregates into the nanoprobe, which specifically responds to nitroreductase and produces strong optoacoustic signals due to its high extinction coefficient, as well as prominent fluorescence emission as a result of its AEE feature. The nanoprobe was used to image tumor metastasis via the lymphatic system both optoacoustically and fluorescently. Moreover, both the fluorescence signals and three-dimensional multispectral optoacoustic tomography signals from the activated nanoprobe allow us to locate the tumor site and to map the metastatic route.
Multiple linker half-squarylium dyes for dye-sensitized solar cells; Are two linkers better than one?
Connell, Arthur,Holliman, Peter J.,Jones, Eurig W.,Furnell, Leo,Kershaw, Christopher,Davies, Matthew L.,Gwenin, Christopher D.,Pitak, Mateusz B.,Coles, Simon J.,Cooke, Graeme
, p. 2883 - 2894 (2015)
The synthesis and full characterization of new half-squaraine dyes (Hf-SQ) containing two or three carboxylate-based linker units is reported and these dyes tested in dye-sensitized solar cell (DSC) devices. The data show improved device efficiency for a Hf-SQ dye with two linkers (η = 5.5%) compared to the highest efficiency Hf-SQ previously reported which had only a single linker (η = 5.0%); this is mainly due to improved Voc. To understand the effects of using multiple dye linker groups, device I-V data have been correlated with single crystal X-ray structural analysis and dye electrical properties (both in solution and adsorbed to TiO2) using UV-visible and ATR-IR spectroscopy along with cyclic voltammetry, and also theoretical studies using density functional theory (DFT) calculations. These data show that positioning the linkers near the dye LUMO and so that this enables complete linker chemisorption are key factors for device performance.
Carboxyl-modified near-infrared squaric acid dye as well as preparation method and application thereof
-
Paragraph 0016, (2021/08/28)
The invention discloses a carboxyl-modified near-infrared squaric acid dye as well as a preparation method and application thereof. The carboxyl-modified near-infrared squaric acid dye is prepared by taking a carboxyl-modified 2-methylbenzothiazole derivative and a dicyanovinyl squaric acid derivative as raw materials. The near-infrared squaric acid dye has relatively good stability and excellent optical performance, and particularly, the water solubility of the dye can be enhanced by carboxylic acid groups. When the near-infrared squaric acid dye is used for detecting parallel and mixed G-quadruplex, the G-quadruplex can interact with dye molecules, and a dye absorption spectrum and a fluorescence emission spectrum are changed while the topological structure of the G-quadruplex is not changed, so that the near-infrared squaric acid dye can be used as a fluorescent probe for detecting the parallel and mixed G-quadruplex.
Cyclic sulfone compound and preparation method, application and pharmaceutical composition thereof
-
Paragraph 0286; 0288; 0289; 0290, (2021/05/29)
The invention belongs to the technical field of pharmacy, and relates to a cyclic sulfone compound and a preparation method, application and a pharmaceutical composition thereof. The cyclic sulfone compound is shown as a formula (I), is a CXCR2 antagonist